Centers for Disease Control and Prevention Centers for Disease Control and Prevention CDC Home Search CDC CDC Health Topics A-Z site search
National Office of Public Health Genomics
Centers for Disease Control and Prevention
Office of Genomics and Disease Prevention
Site Search
 

Family History
Increased Risk for Familial Ovarian Cancer Among Jewish Women: A Population-Based Case-Control Study
Karen K. Steinberg, Janet M. Pernarelli, Michele Marcus, Muin J. Khoury, Joellen M. Schildkraut, Polly A. Marchbank

line

Tables
back to report

TABLE 1: Demographic and risk factor characteristics of women with familial epithelial ovarian cancer, nonfamilial epithileal ovarian cancer, and control women from the cancer and steroid hormone study.

Epithelial ovarian cancer cases
Controls
Variables
Familiala (total = 16)
N (%) 
Nonfamilial (total = 455)
N (%)
(total = 4,025)
Birth year

< 1930

1930-1939

1940+

Unknown

 

4 (25.0)

9 (56.3)

3 (18.8)

0 ( 0.0)

 

85 (18.7)

204 (44.8)

166 (36.5)

0 ( 0.0)

 

653 (16.2)

1,846 (45.9)

1,526 (37.9)

0 ( 0.0)

Menopause status

Premenopausal

Perimenopausal

Natural menopause

Surgical menopause

Unknown

 

4 (25.0)

2 (12.5)

7 (43.8)

2 (12.5)

1 ( 6.3)

 

197 (43.3)

96 (21.1)

91 (20.0)

46 (10.1)

25 ( 5.5)

 

1,758 (43.7)

813 (20.2)

628 (15.6)

680 (16.9)

144 ( 3.6)

Age at menopause

< 40 years

40 - 49.9

50+

Unknown

 

3 (25.0)

8 (66.7)

1 ( 8.3)

0 ( 0.0)

 

46 (17.8)

145 (56.2)

66 (25.6)

1 (0.4)

 

539 (23.8)

1,259 (55.5)

455 (20.1)

14 ( 0.6)

Total pregnancies

none

1

2-3

>3

Unknown

 

0 (0)

2 (12.5)

7 (43.7)

7 (43.7)

0 ( 0.0)

 

92 (20.2)

65 (14.3)

190 (41.8)

107 (23.5)

1 ( 0.2)

 

397 (9.9)

350 (8.7)

1,623 (40.3)

1,651 (41.0)

4 ( 0.1)

Anovulatory cycles

none

1 - 24

25 - 49

50+

Unknown

 

0 (0)

6 (37.5)

8 (50.0)

2 (12.5)

0 ( 0.0)

 

92 (20.2)

177 (38.9)

141 (31.0)

39 ( 8.6)

6 ( 1.3)

 

397 ( 9.9)

1,215 (30.2)

1,605 (39.9)

748 (18.6)

60 ( 1.5)

Education

<=12th grade

13 - 16

>16

Unknown

 

8 (50.0)

5 (31.3)

3 (18.8)

0 ( 0.0)

 

241 (53.0)

159 (34.9)

55 (12.1)

0 ( 0.0)

 

1,900 (47.2)

1,571 (39.0)

550 (13.7)

4 ( 0.1)

Oral contraceptive use

none

<= 3 mos

> 3 mos

Unknown

 

6 (37.5)

2 (12.5)

8 (50.0)

0 ( 0.0)

 

221 (48.6)

41 (9.0)

191 (42.0)

2 ( 0.4)

 

1,439 (35.8)

240 (6.0)

2,337 (58.1)

9 ( 0.2)

aFamilial ovarian cancer was defined as cases of ovarian cancer among women with first degree relatives (sisters, mothers, daughters- although there were no affected daughters) reported as having ovarian cancer. Twenty three women with ovarian cancer and 128 without were excluded from this analysis because their family history was unknown.

back to report


TABLE 2: Unadjusted odds ratios for ovarian cancer among Jewish women.

Familial ovarian cancera
Non-familial ovarian cancer
Controls
Religion      
Jewish
3
15
107
Non-Jewish
13
440
3,913
Odds ratio
8.4
(2.6 - 28.1)
1.25
(0.72 - 2.1)
1.0

aFamilial ovarian cancer was defined as cases of ovarian cancer among women having a mother, sister, or daughter with ovarian cancer. Five women without ovarian cancer were excluded from this analysis because their religion was unknown, and 23 women with ovarian cancer and 128 without were excluded because their family history was unknown.

back to report


TABLE 3: Crude odds ratios for ovarian cancer among Jewish and non-Jewish women with and without a family history of ovarian cancer and the interaction between family history and religion in Jewish women.a

Cases
Controls
Crude OR
95% CI
Not Jewish/No family history
440
3,875
1.00
_
Jewish/No family history
15
104
1.27
0.74 - 2.19
Not Jewish/Family history
13
38
3.01
1.61 - 5.64
Jewish/Family history
3
3
8.81
2.02 - 38.23

aFive women without ovarian cancer were excluded from this analysis because their religion was unknown, and 23 women with ovarian cancer and 128 without were excluded because their family history was unknown.

back to report

Page last reviewed: January 1, 2001 (archived document)
Page last updated: December 11, 2007
Content Source: National Office of Public Health Genomics